Carbohydrate Counting in Children and Adolescents With Type 1 Diabetes
NCT ID: NCT02350374
Last Updated: 2018-07-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2014-11-17
2016-05-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety of Low and Very Low Carbohydrate Diets in Young Children With Type 1 Diabetes
NCT03862521
Low-carbohydrate Diet in Children with Type 1 Diabetes
NCT05078658
Type One Diabetes and Low Carb Study
NCT02839174
The Impact of a Moderate Carbohydrate Diet in Children With Type 1 Diabetes on Hybrid Closed-loop Therapy
NCT06567158
Timing of Pre-meal Insulin Versus Accurate Carbohydrate Counting in Youth With Type 1 Diabetes
NCT01209312
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aims The investigators hypothesize that children vary greatly their total meal CHO .This is an argument for this technique.
Primary aim :
To assess how children and adolescents (aged 1 to 18) use this possibility to change the amount of CHO at breakfast, at lunch, at snack, at dinner and from day to day.
Secondary aims :
* To identify a correlation between the variation of CHO and environnemental factors such as school or disease and medical factors such as glycemic control and BMI.
* To compare the total CHO intake of our pediatric population with international recommendations Methods A logbook is given to the patient to detail the amount of carbohydrates in the meal and place and event during these meal.
This self monitoring logbook must be completed over 28 days between two consultations.
The investigators will include 80 patients during 18 months
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
carbohydrate counting
patients must fill their logbook during 28 days
carbohydrate counting
patients must fill their logbook with the following data:
* cho amount at breakfast, lunch, snack and dinner
* insulin amount at breakfast, lunch, snack and dinner
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
carbohydrate counting
patients must fill their logbook with the following data:
* cho amount at breakfast, lunch, snack and dinner
* insulin amount at breakfast, lunch, snack and dinner
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* With autoantibodies positive (anti-gad, anti-ia2, anti-islets ) or HLA typing predisposing to type 1 diabetes
* Aged 1 to 18 years
* affiliation to a social security scheme
* Less than three oversights of bolus insulin in the week prior to inclusion
Exclusion Criteria
* Autoantibody negative and HLA does not predispose to type 1 diabetes
* No affiliation to a social security scheme
* More than two omissions of bolus insulin in the week before the inclusion
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Lenval
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie HOFLACK, PhD
Role: PRINCIPAL_INVESTIGATOR
Fondation Lenval
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondation Lenval
Nice, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-HPNCL-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.